Innovations in Resistant Hypertension Management

This chapter explores groundbreaking advancements in treating resistant hypertension, focusing on non-steroidal MRAs and aldosterone synthase inhibitors that promise effective blood pressure control with fewer side effects. The discussion includes renal denervation as a potential procedure and the complexities of evaluating its efficacy and patient acceptance. Furthermore, the chapter emphasizes the importance of accurate diagnostics, particularly regarding renin and aldosterone levels, to guide treatment strategies.